Latest news
MRNA Looks 131.7% Overvalued on GF Value™ Amid Unprofitable Stat - GuruFocusGuruFocus · Thu, 06 Aug 2026 10:26:36 GMTMRNA Looks 131.3% Overvalued on GF Value™ After FDA Influenza Va - GuruFocusGuruFocus · Thu, 06 Aug 2026 10:24:39 GMTModerna (MRNA) Receives FDA Approval for mRNA Flu Vaccine for Ad - GuruFocusGuruFocus · Thu, 06 Aug 2026 05:33:54 GMTMRNA Looks 135.4% Overvalued on GF Value™ - GuruFocusGuruFocus · Tue, 04 Aug 2026 16:07:18 GMTMRNA Maintained by Citigroup -- Price Target Raised to $60 - GuruFocusGuruFocus · Tue, 04 Aug 2026 01:16:03 GMTMRNA Looks 154.4% Overvalued on GF Value™ as Seasonal Flu Vaccine Approval Looms - GuruFocusGuruFocus · Sat, 01 Aug 2026 06:33:45 GMTMRNA Looks 154.4% Overvalued on GF Value™ - GuruFocusGuruFocus · Fri, 31 Jul 2026 12:10:59 GMTMRNA Looks 154.4% Overvalued on GF Value™ Amid Late-Stage Trial Setback - GuruFocusGuruFocus · Fri, 31 Jul 2026 12:02:59 GMT